Imatinib intermediate
Imatinib intermediate is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow. They act as chemical messengers. There are a number of different tyrosine kinases and blocking them stops the cancer cells growing.
152460-10-1:
Specifications:
Intermediate | CAS No’s | API/End Use | Status | Purity |
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 | Imatinib | Commercial | NLT 99% |
4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride | 106261-49-8 | Imatinib | Commercial | NLT 99% |
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine | 152460-09-8 | Imatinib | Commercial |